Hikma Pharmaceuticals USA Inc. recalls Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie G
Recalled September 1, 2021 · FDA recall D-0771-2021 · Hikma Pharmaceuticals USA
Hazard
Labeling: Not elsewhere classified: Mislabeling · FDA Class III
Units
1,152 vials
Sold at
USA nationwide
Description
Labeling: Not elsewhere classified: Mislabeling
Product
Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01
Manufacturer(s)
Hikma Pharmaceuticals USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →